Tandem Diabetes Care Inc (TNDM)
Days of sales outstanding (DSO)
Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Receivables turnover | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
DSO | days | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
December 31, 2024 calculation
DSO = 365 ÷ Receivables turnover
= 365 ÷ —
= —
Based on the provided data, Tandem Diabetes Care Inc's days of sales outstanding (DSO) information is not available for the periods listed from March 31, 2020, to December 31, 2024. Without specific values for DSO, it is challenging to assess the efficiency of the company in collecting its accounts receivable.
DSO is a crucial metric that indicates the average number of days it takes for a company to collect payment after a sale has been made. A lower DSO value typically suggests that the company is efficient in collecting payments from its customers, while a higher DSO may indicate potential issues in receivables management or liquidity.
In the absence of actual DSO figures, it is recommended for investors and analysts to keep an eye on future financial reports to monitor any improvements or deteriorations in Tandem Diabetes Care Inc's DSO metric, as it can provide valuable insights into the company's efficiency in managing its receivables and cash flow.
Peer comparison
Dec 31, 2024